Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).
用于转移性去势抵抗性前列腺癌(mCRPC)和转移性乳腺癌患者的治疗。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.